OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response ....14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.____________________)*
Cardiac Pathways Corporation
----------------------------
(Name of Issuer)
Common Stock, $.001 par value
-----------------------------
(Title of Class of Securities)
141408104
-----------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this
statement / /. (A fee is not required only if the filing
person: (1) has a previous statement on file reporting
beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership
of five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
SEC 1745 (2-95)
CUSIP No.141408104 Page 2 of 5 Pages
--------- --- ---
13G
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Arrow International, Inc.
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP*
(a) / /
(b) / /
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- ------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 614,334
BENEFICIALLY -----------------------------------------
OWNED BY 6. SHARED VOTING POWER
EACH -0-
REPORTING -----------------------------------------
PERSON 7. SOLE DISPOSITIVE POWER
WITH 614,334
-----------------------------------------
8. SHARED DISPOSITIVE POWER
-0-
- ------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
614,334
- ------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
/ /
- ------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.6%
- ------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- ------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
This Information Statement on Schedule 13G is
being filed by the undersigned pursuant to
Securities and Exchange Commission Rule 13d-l(c).
Item l(a). Name of Issuer
-----------------------------
Cardiac Pathways Corporation
Item 1(b). Address of Issuer's Principal
-----------------------------
Executive Offices
-----------------------------
995 Benecia Avenue
Sunnyvale, California 94086
Item 2(a). Name of Person Filing
-----------------------------
Arrow International, Inc.
Item 2(b). Address of Principal Business Office
------------------------------------
3000 Bernville Road
Reading, Pennsylvania 19605
Item 2(c). Citizenship
------------------------------------
Pennsylvania
Item 2(d). Title of Class of Securities
------------------------------------
Common Stock, $.001 par value
Item 2(e). CUSIP Number
------------------------------------
141408104
Item 3. Not Applicable
Page 3 of 5 pages
Item 4. Ownership
---------
(a) Total Amount Beneficially Owned: 614,334*
-------
(b) Percent of Class: 6.6%
---
(c) Number of shares as to which such person has:
(i) sole power to vote or to
direct the vote 614,334
-------
(ii) shared power to vote or to
direct the vote -0-
---
(iii) sole power to dispose or to
direct the disposition of 614,334
-------
(iv) shared power to dispose or to
direct the disposition of -0-
---
Item 5. Ownership of Five Percent or Less of a Class
--------------------------------------------
Not Applicable
Item 6. Ownership of More Than Five Percent on Behalf
---------------------------------------------
of Another Person
-----------------
Not Applicable
Item 7. Identification and Classification of the
----------------------------------------
Subsidiary which Acquired the Security Being
--------------------------------------------
Reported on By the Parent Holding Company
-----------------------------------------
Not Applicable
Item 8. Identification and Classification of Members of
-----------------------------------------------
the Group
---------
Not Applicable
Item 9. Notice of Dissolution of Group
------------------------------
Not Applicable
Item 10. Certification
-------------
Not Applicable
*Includes 7,667 shares of common stock of Cardiac Pathways
Corporation which may be acquired by Arrow International,
Inc. upon exercise of a warrant.
Page 4 of 5 pages
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the
information set forth in this statement is true,
complete and correct.
February 6, 1997
ARROW INTERNATIONAL, INC.
By:/s/ Marlin Miller, Jr.
-----------------------
Marlin Miller, Jr.
President
Page 5 of 5 pages
